Sign in

CIK 0001768446 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Climb Bio, Inc.

Sign in to watch
Ticker
CLYM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
832273741
Phone
1-866-857-2596
Business address
20 WILLIAM STREET, SUITE G50, WELLESLEY HILLS, MA
Former names
Eliem Therapeutics, Inc.
  1. SCHEDULE 13D/A Stake Beneficial Ownership Report
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. S-3ASR Offering Registration Statement
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations · Regulation FD disclosure
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. 8-K Event Regulation FD disclosure · Other events
  9. 8-K Event Regulation FD disclosure · Other events
  10. 4 Option exercise Director acquired 70,000 shares (option exercise)
  11. 4 Planned sale Director sold 100,000 shares at $13.67 ($1,366,820)
  12. 144 Insider Sale of Securities
  13. 8-K Event Regulation FD disclosure
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. 8-K Event Other events
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. SCHEDULE 13D/A Stake Beneficial Ownership Report
  20. 4 Derivatives Options or other derivatives

Page 1 of 17 · 326 filings